Skip to content

Study · Measured the body's own peptide · 2023

3 results

Exploring the potential of humanin as a biomarker for early breast cancer detection: a study of serum levels and diagnostic performance.

Hekım MG, Ozcan S, Yur M, Yıldırım N, Ozcan M

Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals13 Aug 2023Cited by 3 (Europe PMC)

PMID37552125 (opens in a new tab)DOI10.1080/1354750x.2023.2246700 (opens in a new tab)PepBankPUB-37552125
Publisher pagePubMedAsk about this study
Jump to 3 results

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study3

No result from this study comes from a test of the peptide.

Natural levels measured3

These results measure the body's own peptide. Nobody was given the peptide. They are not evidence about taking it. They are left out of key results, evidence counts and charts.

  1. 01HumanEndogenous levelObservational studyOther

    Serum humanin levels were significantly higher in women with invasive ductal breast cancer than in healthy controls.

    In plain wordsHigher levels of the body's own humanin were found in the blood of women with breast cancer than in healthy women.

    Peptide
    Humanin
    Outcome
    IncreaseSerum humanin in breast cancer versus healthy controls
    Study

    n = 90

    Comparator
    Healthy volunteers
    Outcome group
    Aging markers · Cancer

    Source sentences

    Summary
    Our results showed that serum humanin levels were significantly higher in breast cancer patients than in healthy controls (p = 0.008).
    2 context sentences
    Summary · context
    We recruited 45 female patients diagnosed with primary invasive ductal breast cancer and 45 healthy volunteers.
    Summary · context
    Serum humanin levels were measured using ELISA, and other cancer markers were measured using an Advia Centaur Immunology Analyser.

    This result measures the body's own Humanin. Nobody was given the peptide. It is not evidence about taking it.

  2. 02HumanEndogenous levelObservational studyOther

    In ROC analysis, serum humanin discriminated breast cancer patients from healthy individuals with a sensitivity of 62.5%.

    In plain wordsA blood test for the body's own humanin picked out 62.5% of women with breast cancer.

    Peptide
    Humanin
    Outcome
    Not applicableSensitivity of humanin for breast cancer (ROC)
    Study

    n = 90

    Outcome group
    Aging markers · Cancer

    Measurements

    Sensitivity
    62.5%
    serum humanin ROC analysis

    Source sentences

    Summary
    ROC curve analysis indicated that humanin could effectively discriminate between patients and healthy individuals, with a sensitivity of 62.5% and a specificity of 77.5%.
    2 context sentences
    Summary · context
    We recruited 45 female patients diagnosed with primary invasive ductal breast cancer and 45 healthy volunteers.
    Summary · context
    Serum humanin levels were measured using ELISA, and other cancer markers were measured using an Advia Centaur Immunology Analyser.

    This result measures the body's own Humanin. Nobody was given the peptide. It is not evidence about taking it.

  3. 03HumanEndogenous levelObservational studyOther

    In ROC analysis, serum humanin discriminated breast cancer patients from healthy individuals with a specificity of 77.5%.

    In plain wordsA blood test for the body's own humanin correctly cleared 77.5% of healthy women.

    Peptide
    Humanin
    Outcome
    Not applicableSpecificity of humanin for breast cancer (ROC)
    Study

    n = 90

    Outcome group
    Aging markers · Cancer

    Measurements

    Specificity
    77.5%
    serum humanin ROC analysis

    Source sentences

    Summary
    ROC curve analysis indicated that humanin could effectively discriminate between patients and healthy individuals, with a sensitivity of 62.5% and a specificity of 77.5%.
    2 context sentences
    Summary · context
    We recruited 45 female patients diagnosed with primary invasive ductal breast cancer and 45 healthy volunteers.
    Summary · context
    Serum humanin levels were measured using ELISA, and other cancer markers were measured using an Advia Centaur Immunology Analyser.

    This result measures the body's own Humanin. Nobody was given the peptide. It is not evidence about taking it.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    13 Oct 2026, 21:44 UTC

    Study results updated

  2. Version 1

    13 Oct 2026, 16:31 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

Publication types

PepBank is a research reference. Talk to a doctor before you use any peptide.